Advancing the Diagnosis and Management of Cardiac Amyloidosis

Cardiac amyloidosis remains an under-recognised cause of heart failure. Too often, patients are treated for “standard” heart failure for months or even years before the underlying diagnosis is identified. Yet we now know that early recognition and timely intervention can significantly improve outcomes and quality of life. Kent and London Cardiology’s Dr Suzan Hatipoglu explains recent developments.